NCT02383316View on ClinicalTrials.gov

Study of Metabolic Modifications in Children With Noonan Syndrome

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Child Syndrome
Interventions
OTHER

Oral Glucose tolerance test

Oral glucose tolerance test (OGTT): glucose and insulin levels will be measured at time points 0, 90 and 120 min or 30, 60, 90 and 120 after 1.75 g/Kg (max 75 g) glucose administration depending of the patient weight.

Trial Locations (1)

31052

CHU Toulouse - Hôpital des Enfants, Toulouse

All Listed Sponsors
lead

University Hospital, Toulouse

OTHER

NCT02383316 - Study of Metabolic Modifications in Children With Noonan Syndrome | Biotech Hunter | Biotech Hunter